| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 05/11/2011 | EP1827504B1 Recombinant bcg strains with enhanced ability to escape the endosome |
| 05/11/2011 | EP1803811B1 Chimeric (double) decoy |
| 05/11/2011 | EP1678497B1 Methods and compositions for modulating apoptosis |
| 05/11/2011 | EP1381280B1 Viral vectors and their use in therapeutic methods |
| 05/11/2011 | EP1161227B1 Microparticles for delivery of nucleic acid |
| 05/11/2011 | EP0885002B1 Materials and methods for enhancing cellular internalization |
| 05/11/2011 | CN1688695B New dendritic cell co stimulatory molecules |
| 05/11/2011 | CN102056631A Apoptosis inducer |
| 05/11/2011 | CN102051362A Interference RNA (Ribonucleic Acid) of targeted HPIP (hematopoietic PBX-interacting protein) gene, medical composition containing same and application thereof |
| 05/11/2011 | CN102051361A Small interfering ribonucleic acid (siRNA) for inhibiting human AE1 gene expression, expression plasmid thereof, and application thereof to pharmacy |
| 05/11/2011 | CN102051358A Mosaic tumor specific gene expression regulation kit and application thereof |
| 05/11/2011 | CN102049048A Method of treatment or prophylaxis |
| 05/11/2011 | CN102049039A Application of p65 in preparation of medicament for up-regulating SIRT1 expression |
| 05/11/2011 | CN101638656B Blood serum/blood plasma miRNA marker related to non-small cell lung cancer (SCLC) prognosis and application thereof |
| 05/11/2011 | CN101537191B Recomposed tPA gene-chitosan nanoparticle complex and preparation method thereof |
| 05/11/2011 | CN101353647B Simulating retrovirus of target tumor, and preparation and use thereof |
| 05/11/2011 | CN101348786B Human beta-globin gene and recombinant adenovirus related virus vector thereof |
| 05/11/2011 | CN101280318B Recombinant human HNP gene liposome complex, preparation and use thereof |
| 05/11/2011 | CN101072879B Improved adenoviral vectors and uses thereof |
| 05/10/2011 | US7939683 Phospholipid-analogous compounds |
| 05/10/2011 | US7939677 Oligomeric compounds comprising 4′-thionucleosides for use in gene modulation |
| 05/10/2011 | US7939654 Platelet derived growth factor (PDGF) nucleic acid ligand complexes |
| 05/10/2011 | US7939652 Oligoribonucleotides and methods of use thereof for treatment of fibrotic conditions and other diseases |
| 05/10/2011 | US7939650 For stimulating release of tumor necrosis factor and/or cellular prolifefration/differentiation of chondrocytes by contacting blood w/polypeptide; diagnosis cancer |
| 05/10/2011 | US7939646 Compositions and methods for the therapy and diagnosis of prostate cancer |
| 05/10/2011 | US7939505 Amino acid lipids and uses thereof |
| 05/10/2011 | US7939504 Method of treating skin ulcers with vectors encoding hepatocyte growth factor |
| 05/10/2011 | US7939318 Flexible vaccine assembly and vaccine delivery platform |
| 05/10/2011 | US7939292 Modified heparinase III and methods of sequencing therewith |
| 05/10/2011 | US7939253 detecting in a test sample to be analyzed for Ewing's sarcoma, expression of NKX2.2; (comparing the expression of NKX2.2 in the test sample to the expression of NKX2.2 in a control, (cells where Ewing's sarcoma iabsent); histone deacetylase inhibitor is suberoylanilide hydroxamic acid or Trichostatin A |
| 05/10/2011 | US7939086 Modified Vaccinia Ankara virus variant |
| 05/10/2011 | US7939063 Delivery vehicle for recombinant proteins |
| 05/10/2011 | US7939059 Method for the generation of antigen-specific lymphocytes |
| 05/10/2011 | US7939057 Methods and compositions for modulating the mobilization of stem cells |
| 05/10/2011 | CA2457057C Compositions and methods for treating neurodegenerative diseases |
| 05/10/2011 | CA2439170C Methods for identifying compounds for regulating muscle mass or function using corticotropin releasing factor receptors |
| 05/10/2011 | CA2411056C Pharmaceutical compositions containing prostacyclin synthase gene |
| 05/10/2011 | CA2406664C Systemic delivery of neural stem cells to treat cancer |
| 05/10/2011 | CA2379346C Conjugate for mediating cell-specific, compartment-specific or membrane-specific transport of active substances |
| 05/10/2011 | CA2344590C Treatment of inflammatory disease |
| 05/10/2011 | CA2292898C Bacterial pheromones and uses therefor |
| 05/10/2011 | CA2248016C Direct molecular diagnosis of friedreich ataxia |
| 05/10/2011 | CA2171589C Phosphonomonoester nucleic acids, process for their preparation, and their use |
| 05/10/2011 | CA2165458C Intracellular binding proteins and use thereof |
| 05/05/2011 | WO2011054011A2 Foot and mouth disease virus (fmdv) consensus proteins, coding sequences therefor and vaccines made therefrom |
| 05/05/2011 | WO2011053989A2 Polymeric materials loaded with mutagenic and recombinagenic nucleic acids |
| 05/05/2011 | WO2011053940A2 Templated nanoconjugates |
| 05/05/2011 | WO2011053896A2 Hypoxia regulated conditionally silenced aav expressing angiogenic inducers |
| 05/05/2011 | WO2011053660A2 Novel therapeutic rna interference technology targeted to the pdx-1 oncogene in pdx-1 expressing neuroendocrine tumors |
| 05/05/2011 | WO2011052771A1 Nebulizable tuberculosis vaccine for transnasal administration comprising paramyxovirus vector |
| 05/05/2011 | WO2011052715A1 Modified double-stranded polynucleotide |
| 05/05/2011 | WO2011052668A1 Tissue-regeneration promoter using recruitment of bone marrow mesenchymal stem cells and/or pluripotent stem cells in blood |
| 05/05/2011 | WO2011051450A1 Cardiac-specific nucleic acid regulatory elements and methods and use thereof |
| 05/05/2011 | US20110107444 Novel poly(adp-ribose) polymerase genes |
| 05/05/2011 | US20110107443 Novel protein transduction domains derived from secretory leukocyte protease inhibitor |
| 05/05/2011 | US20110105731 Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods based thereon |
| 05/05/2011 | US20110105721 Peptides |
| 05/05/2011 | US20110105718 Nel-related protein type 1 antibody |
| 05/05/2011 | US20110105592 Anti-sense microrna expression vectors |
| 05/05/2011 | US20110105590 Compositions And Methods For Inhibiting Expression Of Anti-Apoptotic Genes |
| 05/05/2011 | US20110104706 Novel kinases and uses thereof |
| 05/05/2011 | US20110104227 Absorbable polyethylene diglycolate copolymers to reduce microbial adhesion to medical devices and implants |
| 05/05/2011 | US20110104199 MVA Expressing Modified HIV Envelope, GAG, and POL Genes |
| 05/05/2011 | US20110104132 Fgf-9 and its use relating to blood vessels |
| 05/05/2011 | US20110104131 Hematopoietic stem cells and methods of treatment of neovascular eye diseases therewith |
| 05/05/2011 | US20110104118 Compositions and methods for therapeutic use |
| 05/05/2011 | US20110104117 Metabolically activated recombinant viral vectors and methods for their preparation and use |
| 05/05/2011 | US20110104059 Membrane Associated Tumor Endothelium Markers |
| 05/05/2011 | US20110104050 Compositions and Methods for Identifying and Targeting Cancer Cells of Alimentary Canal Origin |
| 05/05/2011 | CA2779118A1 Hypoxia regulated conditionally silenced aav expressing angiogenic inducers |
| 05/05/2011 | CA2778945A1 Cardiac-specific nucleic acid regulatory elements and methods and use thereof |
| 05/05/2011 | CA2778759A1 Tissue-regeneration promoter using recruitment of bone marrow mesenchymal stem cells and/or pluripotent stem cells in blood |
| 05/05/2011 | CA2777539A1 Novel therapeutic rna interference technology targeted to the pdx-1 oncogene in pdx-1 expressing neuroendocrine tumors |
| 05/04/2011 | EP2316976A1 Expression analysis of FKBP nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer |
| 05/04/2011 | EP2316968A1 Antisense modulation of apolipoprotein (A) expression |
| 05/04/2011 | EP2316935A1 Aptamer against il-17 and use thereof |
| 05/04/2011 | EP2316925A1 Circovirus sequences associated with porcine wasting disease (PWD) |
| 05/04/2011 | EP2316919A1 Post-partum mammalian placenta, its use and placental stem cells therefrom |
| 05/04/2011 | EP2316918A1 Post-partum mammalian placenta, its use and placental stem cells therefrom |
| 05/04/2011 | EP2316844A2 Peptide complex |
| 05/04/2011 | EP2316531A1 Augmented cognitive training |
| 05/04/2011 | EP2316491A1 Cell proliferation inhibitor |
| 05/04/2011 | EP2315833A2 Vectors for delivery of light-sensitive proteins and methods of use |
| 05/04/2011 | EP2315776A2 T cell receptors and related materials and methods of use |
| 05/04/2011 | EP2128248B1 Oligonucleotide compositions with enhanced efficiency |
| 05/04/2011 | EP2022851B1 Method of transferring substance into cell |
| 05/04/2011 | EP1725660B1 Multiple promoter expression cassettes for simultaneous delivery of rnai agents |
| 05/04/2011 | EP1629091B1 Composition containing the polyprotein ns3/ns4 and the polypeptide ns5b of hcv, expression vectors comprising corresponding nucleic sequences and the therapeutic application thereof |
| 05/04/2011 | CN1931371B Application of siRNA suppressing human Ezrin gene expression in the research on esophagus carcinoma proliferation |
| 05/04/2011 | CN1856576B Adeno-associated virus (aav) clades, sequences, vectors containing same, and uses therefor |
| 05/04/2011 | CN1500147B Improved gene expression |
| 05/04/2011 | CN102046780A Method for production of transfected cell |
| 05/04/2011 | CN102046208A Composition for external application comprising transcription factor decoy as active ingredient |
| 05/04/2011 | CN102041316A Application of micro ribonucleic acid (miRNA)-219 compound as marker of brain glioma |
| 05/04/2011 | CN102041270A Construction and screening of siRNAs (small interfering RANs) expression vectors of targeted DEC1 (differentiated embryo-chondrocyte expressed gene 1) resulting in gastric cancer and application thereof |
| 05/04/2011 | CN102041265A Immunoassay reagent for assaying influenza A H1N1 virus antigen |
| 05/04/2011 | CN102041259A GPR116 (G-protein coupled Receptor) gene, receptor protein coded by same and application of the GPR116 gene |
| 05/04/2011 | CN102041256A Human miR-486-5p antisense nucleic acid and application thereof |
| 05/04/2011 | CN102038960A Method for preparing outer membrane protein H and A genes of fowl cholera and fused DNA vaccine |
| 05/04/2011 | CN102038959A Application of let-7/miR-98 family in preparation of medicament for treating disease related to FAS (Fatty Acid Synthase) gene |